Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Special or Theme Issue

Risk Evaluation and Mitigation Strategy (REMS) Programs and Medication Safety: Parts I and II.

Risk Evaluation and Mitigation Strategy (REMS) Programs and Medication Safety: Parts I and II. ISMP Medication Safety Alert! Acute care edition. July 13, 2023;(4):1-3;July 27, 2023;(5):1-5.

Save
Print
August 9, 2023

ISMP Medication Safety Alert! Acute care edition. July 13, 2023;(4):1-3;July 27, 2023;(5):1-5.

Risk Evaluation and Mitigation Strategy (REMS) programs help to ensure the safe use of distinct medications through communication, patient information, and implementation support. Part I of this article series examines systemic barriers to the deployment of REMS as a strategy to decrease potential for drug-related harm and medication error. Part II looks at the processes that one health system used to implement REMS.

Save
Print
Cite
Citation

Risk Evaluation and Mitigation Strategy (REMS) Programs and Medication Safety: Parts I and II. ISMP Medication Safety Alert! Acute care edition. July 13, 2023;(4):1-3;July 27, 2023;(5):1-5.